Home › Funds › Soleus Capital Management, L.P. › AMRX
Soleus Capital Management, L.P. position in AMRX
AMNEAL PHARMACEUTICALS INC · Health Care
Soleus Capital Management, L.P. reported holding 658,000 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$13.3M, representing 0.47% of its reported portfolio and ranking #49 among its reported holdings. Soleus Capital Management, L.P. first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Soleus Capital Management, L.P.'s AMRX position evolved
Soleus Capital Management, L.P. first disclosed a stake in AMRX in Q3 2026 at 658,000 shares (US$13.3M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 658.00K | $13.25M | New |
About AMRX and 13F data
AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 47 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$248.3M), Rubric Capital Management LP (US$171.9M), Tri Locum Partners LP (US$46.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMRX
- TPG GP A, LLC 12.33M sh · $248.30M · Q3 2026
- Rubric Capital Management LP 8.54M sh · $171.93M · Q3 2026
- Tri Locum Partners LP 2.33M sh · $46.86M · Q3 2026
- Nantahala Capital Management, LLC 2.12M sh · $42.61M · Q3 2026
- Westshore Wealth, LLC 1.37M sh · $23.65M · Q2 2026
- PFM Health Sciences, LP 822.89K sh · $16.57M · Q3 2026
- Phocas Financial Corp. 819.48K sh · $14.19M · Q2 2026
More on Soleus Capital Management, L.P.
FAQ
How long has Soleus Capital Management, L.P. held AMRX?
Soleus Capital Management, L.P. has disclosed AMRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Soleus Capital Management, L.P.'s current position in AMRX?
As of Q3 2026, Soleus Capital Management, L.P. holds 658.00K shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $13.25M, representing 0.47% of its reported portfolio and ranking #49.
Has Soleus Capital Management, L.P. been buying or selling AMRX?
In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. newly opened its position in AMRX.
Which other funds hold AMRX?
Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Tri Locum Partners LP, among 47 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.